Tessera Therapeutics Company
In recent years, we’ve made extraordinary leaps in genetic medicine, with two pillar technologies emerging: gene therapy and gene editing. While these methods represent major advancements, they are not without significant limitations.
Founded Date:
2018
Total Funding:
230M
Investor Type:
Early Stage Venture
Employee Number:
11-50
Funding Status:
Series B
Number Of Exists:
11-50
Technology:
Others
Last Funding Type:
Series B
Investors Number:
6
Last Funding Date:
Jan 12, 2021
Industry:
Biopharma, Biotechnology, Gene therapy, Therapeutics
Headquarters:
Cambridge, Massachusetts, United States